Wild-type macrophages reverse disease in heme oxygenase 1-deficient mice

Blood

Volumn 124, Issue 9, 2014, Pages 1522-1530

  Kovtunovych, Gennadiy ^a   Ghosh, Manik C ^a   Ollivierre, Wade ^a   Weitzel, R Patrick ^b   Eckhaus, Michael A ^c   Tisdale, John F ^b   Yachie, Akihiro ^d   Rouault, Tracey A ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HEME OXYGENASE 1; RAPAMYCIN; HEME; HMOX1 PROTEIN, HUMAN; HMOX1 PROTEIN, MOUSE; IRON; MEMBRANE PROTEIN;

ANEMIA; ANIMAL EXPERIMENT; ARTICLE; BLOOD CHEMISTRY; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; ENGRAFTMENT; ENZYME DEFICIENCY; ERYTHROCYTE; GENETIC DISORDER; HEME OXYGENASE 1 DEFICIENCY; IMMUNOHISTOCHEMISTRY; INTRAVASCULAR HEMOLYSIS; IRON METABOLISM; KIDNEY INJURY; KUPFFER CELL; LEUKOCYTE; MACROPHAGE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANEMIA, HEMOLYTIC, CONGENITAL; ANIMAL; C57BL MOUSE; DEFICIENCY; DISEASE MODEL; FEMALE; GENETICS; HUMAN; KIDNEY; KNOCKOUT MOUSE; MALE; METABOLISM; PATHOLOGY; TRANSPLANTATION;

ANEMIA, HEMOLYTIC, CONGENITAL; ANIMALS; BONE MARROW TRANSPLANTATION; DISEASE MODELS, ANIMAL; FEMALE; HEME; HEME OXYGENASE-1; HUMANS; IRON; KIDNEY; KUPFFER CELLS; MACROPHAGES; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OXIDATIVE STRESS;

EID: 84907357919     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2014-02-554162     Document Type: Article

References (38)

1. Yachie A, Niida Y, Wada T, et al. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest. 1999; 103(1):129-135.
2. Poss KD, Tonegawa S. Heme oxygenase 1 is required for mammalian iron reutilization. Proc Natl Acad Sci USA. 1997;94(20):10919-10924.
3. Kawashima A, Oda Y, Yachie A, Koizumi S, Nakanishi I. Heme oxygenase-1 deficiency: the first autopsy case. Hum Pathol. 2002;33(1): 125-130.
4. Radhakrishnan N, Yadav SP, Sachdeva A, Wada T, Yachie A. An interesting tetrad of asplenia, inflammation, hemolysis, and nephritis. Pediatr Hematol Oncol. 2011;28(8):723-726.
5. Radhakrishnan N, Yadav SP, Sachdeva A, et al. Human heme oxygenase-1 deficiency presenting with hemolysis, nephritis, and asplenia. J Pediatr Hematol Oncol. 2011;33(1):74-78.
6. Kovtunovych G, Eckhaus MA, Ghosh MC, Ollivierre-Wilson H, Rouault TA. Dysfunction of the heme recycling system in heme oxygenase 1-deficient mice: effects on macrophage viability and tissue iron distribution. Blood. 2010;116(26): 6054-6062.
7. Hvidberg V, Maniecki MB, Jacobsen C, Højrup P, Møller HJ, Moestrup SK. Identification of the receptor scavenging hemopexin-heme complexes. Blood. 2005;106(7):2572-2579.
8. Moestrup SK, Møller HJ. CD163: a regulated hemoglobin scavenger receptor with a role in the anti-inflammatory response. Ann Med. 2004; 36(5):347-354.
9. Nielsen MJ, Andersen CB, Moestrup SK. CD163 binding to haptoglobin-hemoglobin complexes involves a dual-point electrostatic receptor-ligand pairing. J Biol Chem. 2013;288(26):18834-18841.
10. Maniecki MB, Hasle H, Friis-Hansen L, et al. Impaired CD163-mediated hemoglobinscavenging and severe toxic symptoms in patients treated with gemtuzumab ozogamicin. Blood. 2008;112(4):1510-1514.
11. Tolosano E, Fagoonee S, Hirsch E, et al. Enhanced splenomegaly and severe liver inflammation in haptoglobin/hemopexin doublenull mice after acute hemolysis. Blood. 2002; 100(12):4201-4208.
12. Belcher JD, Beckman JD, Balla G, Balla J, Vercellotti G. Heme degradation and vascular injury. Antioxid Redox Signal. 2010;12(2): 233-248.
13. Bolisetty S, Traylor AM, Kim J, et al. Heme oxygenase-1 inhibits renal tubular macroautophagy in acute kidney injury. J Am Soc Nephrol. 2010;21(10):1702-1712.
14. LaVaute T, Smith S, Cooperman S, et al. Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice. Nat Genet. 2001;27(2):209-214.
15. Hsieh MM, Langemeijer S, Wynter A, Phang OA, Kang EM, Tisdale JF. Low-dose parenteral busulfan provides an extended window for the infusion of hematopoietic stem cells in murine hosts. Exp Hematol. 2007;35(9):1415-1420.
16. Gburek J, Verroust PJ, Willnow TE, et al. Megalin and cubilin are endocytic receptors involved in renal clearance of hemoglobin. J Am Soc Nephrol. 2002;13(2):423-430.
17. Starzyński RR, Canonne-Hergaux F, Lenartowicz M, et al. Ferroportin expression in haem oxygenase 1-deficient mice. Biochem J. 2013; 449(1):69-78.
18. Shelton LM, Park BK, Copple IM. Role of Nrf2 in protection against acute kidney injury. Kidney Int. 2013;84(6):1090-1095.
19. Singh S, Vrishni S, Singh BK, Rahman I, Kakkar P. Nrf2-ARE stress response mechanism: a control point in oxidative stress-mediated dysfunctions and chronic inflammatory diseases. Free Radic Res. 2010;44(11):1267-1288.
20. Sadrzadeh SM, Bozorgmehr J. Haptoglobin phenotypes in health and disorders. Am J Clin Pathol. 2004;121(1 Suppl):S97-S104.
21. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol. 2005;5(12): 953-964.
22. Polfliet MM, Fabriek BO, Daniëls WP, Dijkstra CD, van den Berg TK. The rat macrophage scavenger receptor CD163: expression, regulation and role in inflammatory mediator production. Immunobiology. 2006;211(6-8):419-425.
23. Fabriek BO, Polfliet MM, Vloet RP, et al. The macrophage CD163 surface glycoprotein is an erythroblast adhesion receptor. Blood. 2007; 109(12):5223-5229.
24. Fabriek BO, Dijkstra CD, van den Berg TK. The macrophage scavenger receptor CD163. Immunobiology. 2005;210(2-4):153-160.
25. Barbé E, Huitinga I, Döpp EA, Bauer J, Dijkstra CD. A novel bone marrow frozen section assay for studying hematopoietic interactions in situ: the role of stromal bone marrow macrophages in erythroblast binding. J Cell Sci. 1996;109(Pt 12): 2937-2945.
26. Hsieh MM, Kang EM, Fitzhugh CD, et al. Allogeneic hematopoietic stem-cell transplantation for sickle cell disease. N Engl J Med. 2009;361(24):2309-2317.
27. Hsieh MM, Fitzhugh CD, Tisdale JF. Allogeneic hematopoietic stem cell transplantation for sickle cell disease: the time is now. Blood. 2011;118(5): 1197-1207.
28. Takahashi K. Development and differentiation of macrophages and related cells: historical review and current concepts. J Clin Exp Hematop. 2000;41(1):1-31.
29. Sieweke MH, Allen JE. Beyond stem cells: selfrenewal of differentiated macrophages. Science. 2013;342(6161):1242974.
30. Yona S, Kim KW, Wolf Y, et al. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity. 2013;38(1):79-91.
31. Aziz A, Soucie E, Sarrazin S, Sieweke MH. MafB/c-Maf deficiency enables self-renewal of differentiated functional macrophages. Science. 2009;326(5954):867-871.
32. Hashimoto D, Chow A, Noizat C, et al. Tissueresident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes. Immunity. 2013; 38(4):792-804.
33. Ramos P, Casu C, Gardenghi S, et al. Macrophages support pathological erythropoiesis in polycythemia vera and b-thalassemia. Nat Med. 2013;19(4):437-445.
34. Cong L, Ran FA, Cox D, et al. Multiplex genome engineering using CRISPR/Cas systems. Science. 2013;339(6121):819-823.
35. Dong A, Rivella S, Breda L. Gene therapy for hemoglobinopathies: progress and challenges. Transl Res. 2013;161(4):293-306.
36. Mali P, Yang L, Esvelt KM, et al. RNA-guided human genome engineering via Cas9. Science. 2013;339(6121):823-826.
37. Romero Z, Urbinati F, Geiger S, et al. b-globin gene transfer to human bone marrow for sickle cell disease [published online ahead of print July 1, 2013]. J Clin Invest.
38. Ye L, Swingen C, Zhang J. Induced pluripotent stem cells and their potential for basic and clinical sciences. Curr Cardiol Rev. 2013;9(1):63-72.